Israel Madera

Israel Madera has extensive experience in the medical and healthcare industry. Israel'swork history began in 2001 when they were a Marketing Manager for WellCheck, which was later acquired by Impact Health. In 2002, they joined Eli Lilly as a Neuroscience Pharmaceutical Representative. In 2005, they became a Marketing Manager for Oncology at Medtronic (formerly Kyphon). In 2008, they were a Senior Product Manager for EsophyX at EndoGastric Solutions. From 2009 to 2012, they were a Global Product Manager for the NanoKnife System at AngioDynamics. From 2012 to 2014, they were a Senior Product Marketing Manager at TriReme Medical, LLC, which was later acquired by Medtronic. From 2015 to 2020, they were the Vice President of Marketing and Clinical at Sanarus Technologies, which was later acquired by Hologic. Since 2020, they have been a Senior Director of US Marketing at Agendia. Most recently, in 2022, they became the Senior Director of Marketing at Tulavi Therapeutics.

Israel Madera attended Golden Gate University from 1996 to 1998, where they earned a Master's degree in Marketing. Israel then attended California Polytechnic State University-San Luis Obispo from 1988 to 1993, where they earned a Bachelor's degree in Architecture.